• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Monday, June 5, 2023
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Graphenest and Hubron to explore development and commercialization of graphene

Bioengineer by Bioengineer
March 28, 2023
in Science News
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

In February of this year, Graphene Flagship associated member Graphenest and manufacturing company Hubron International entered a new strategic partnership. Their shared aim is to explore the development and commercialization of graphene-based polymer masterbatch and compounds with unprecedented electromagnetic interference (EMI) shielding performance for electronic enclosures manufacturing.

Electronics

Credit: Graphenest

In February of this year, Graphene Flagship associated member Graphenest and manufacturing company Hubron International entered a new strategic partnership. Their shared aim is to explore the development and commercialization of graphene-based polymer masterbatch and compounds with unprecedented electromagnetic interference (EMI) shielding performance for electronic enclosures manufacturing.

This new product line will start with a graphene-based thermoplastic suitable to be implemented as a remarkable EMI shielding solution in medium-high and high frequencies (for 5G and beyond).

The agreement brings together Graphenest’s knowledge around graphene production, the development of shielding products, and IP expertise, and Hubron International’s expertise as a specialist in black masterbatch and conductive polymers for Electric and Electronics parts.

An associated member of the Graphene Flagship since 2017, Graphenest is a nanotechnology company that has been involved in multiple pioneering endeavors – including the partnering project NeuroStimSpinal, which has been developing materials for the recovery of spinal cord injuries. Graphenest provides automotive and electronics sectors with conductive graphene-based EMI shielding solutions. Its primary objective is to replace metals with cost-effective, ultralightweight, and sustainable conductive coatings and plastic systems.

Hubron International is a leading global specialist in masterbatch. They have an extensive portfolio of specialist grades including conductive compounds, engineering masterbatches, specialist polymers, additive masterbatches with graphene, graphite and other materials to improve end-product properties and performance.

Thanks to new work in this space, the market is now able to use graphene-based shielding solutions to replace the conventional dense, rigid, and time and energy-intensive old-metal enclosures.

“The usage of polymeric compounds based on graphene that can effectively shield high concentrations of microwaves and millimeter waves (5G/6G) will be crucial in the near future,” says Bruno Figueiredo, Graphenest’s co-CEO.

“We are observing a rise in interest, mostly because more electronics and e-mobility devices are linking to one another. As a result, we can no longer completely rely on traditional, unsustainable metals.”

With this in mind, the collaboration between Graphenest and Hubron is especially welcome.

“The combination between Graphenest technology and Hubron’s masterbatch and compound expertise will boost the innovation towards the best conductive polymers, specially made for the E-mobility and Electronics industries”, says Robert Laurent, Technical Director of Hubron International.

Here at the Graphene Flagship, we are looking forward to seeing how this new collaboration will bring even more different coatings and plastic compound solutions into the market.

 



Share12Tweet8Share2ShareShareShare2

Related Posts

Dr. Alex Herrera

Phase 3 SWOG Cancer Research Network trial, led by a City of Hope researcher, demonstrates one-year progression-free survival in 94% of patients with Stage 3 or 4 classic Hodgkin lymphoma who received a checkpoint inhibitor combined with chemotherapy

June 4, 2023
Ana Oaknin, Principal Investigator of the Vall d’Hebron Institute of Oncology’s (VHIO) Gynecological Malignancies Group

The promise of novel FolRα-targeting antibody drug conjugate in recurrent epithelial ovarian cancer

June 3, 2023

Carbon-based stimuli-responsive nanomaterials: classification and application

June 3, 2023

ASCO: Targeted therapy induces responses in HER2-amplified biliary tract cancer

June 3, 2023

POPULAR NEWS

  • plants

    Plants remove cancer causing toxins from air

    40 shares
    Share 16 Tweet 10
  • Element creation in the lab deepens understanding of surface explosions on neutron stars

    36 shares
    Share 14 Tweet 9
  • Deep sea surveys detect over five thousand new species in future mining hotspot

    35 shares
    Share 14 Tweet 9
  • How life and geology worked together to forge Earth’s nutrient rich crust

    35 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Phase 3 SWOG Cancer Research Network trial, led by a City of Hope researcher, demonstrates one-year progression-free survival in 94% of patients with Stage 3 or 4 classic Hodgkin lymphoma who received a checkpoint inhibitor combined with chemotherapy

The promise of novel FolRα-targeting antibody drug conjugate in recurrent epithelial ovarian cancer

Carbon-based stimuli-responsive nanomaterials: classification and application

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 50 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In